The role of psychological resilience, severity of disease and treatment adherence in the prediction of health-related quality of life in patients with multiple sclerosis

被引:0
作者
Hadianfard, Habib [1 ]
Ashjazadeh, Nahid [2 ]
Feridoni, Soodabe [1 ]
Farjam, Elham [1 ]
机构
[1] Shiraz Univ, Dept Clin Psychol, Shiraz, Iran
[2] Shiraz Univ Med Sci, Dept Neurol, Shiraz Neurosci Res Ctr, Shiraz, Iran
关键词
MODIFYING THERAPIES; SURVEY SF-36; IMPACT; SCALE;
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: This cross-sectional study aims to evaluate the impact of the disability status, psychological resilience, and treatment adherence on health-related quality of life (QOL) in patients with multiple sclerosis (MS). Methods: One hundred MS outpatients, 80 women and 20 men, referred to a clinic of Shiraz University of Medical Sciences, were eligible to participate. MS was diagnosed by 2010 revised Mc-Donald criteria. The QOL and resilience were evaluated by the Medical Outcomes Study Short-Form (SF-36) and Connor-Davidson Resilience Scale (CD-RISC) respectively. Medication adherence and severity of disease were assessed by the Morisky Medication Adherence Scale (MMAS) and expanded disability status state (EDSS) scores respectively. Results: Stepwise multiple regressions showed that in the first model, the disability status was the best predictor which accounted for 28.1% of the variance in QOL. In the second model, both the disability status and resilience explained 50.6% of the variation in QOL. Conclusion: The findings showed that the severity of the disease is a strong predictor which has adverse effects on the physical component of health-related QOL in the patients with MS. Both psychological resilience and treatment adherence have positive influence on mental component of QOL in these patients.
引用
收藏
页码:263 / 268
页数:6
相关论文
共 23 条
[1]  
[Anonymous], 2015, COGENT PSYCHOL, DOI DOI 10.1080/23311908.2015.1024928
[2]  
Bakaeian M, 2012, THESIS
[3]   Development of a new resilience scale: The Connor-Davidson Resilience scale (CD-RISC) [J].
Connor, KM ;
Davidson, JRT .
DEPRESSION AND ANXIETY, 2003, 18 (02) :76-82
[4]   The Global Adherence Project (GAP): a multicenter observational study on adherence to disease-modifying therapies in patients with relapsing-remitting multiple sclerosis [J].
Devonshire, V. ;
Lapierre, Y. ;
Macdonell, R. ;
Ramo-Tello, C. ;
Patti, F. ;
Fontoura, P. ;
Suchet, L. ;
Hyde, R. ;
Balla, I. ;
Frohman, E. M. ;
Kieseier, B. C. .
EUROPEAN JOURNAL OF NEUROLOGY, 2011, 18 (01) :69-77
[5]  
Falk-Kessler Janet, 2012, Int J MS Care, V14, P160, DOI 10.7224/1537-2073-14.3.160
[6]   RESILIENCE AND HUMAN ADAPTABILITY - WHO RISES ABOVE ADVERSITY - 1990 SLAGLE,ELEANOR,CLARKE LECTURE [J].
FINE, SB .
AMERICAN JOURNAL OF OCCUPATIONAL THERAPY, 1991, 45 (06) :493-503
[7]   Efficacy of disease-modifying therapies in relapsing remitting multiple sclerosis: A systematic comparison [J].
Freedman, Mark S. ;
Hughes, Bruce ;
Mikol, Daniel D. ;
Bennett, Randy ;
Cuffel, Brian ;
Divan, Vamil ;
LaVallee, Nicole ;
Al-Sabbagh, Ahmad .
EUROPEAN NEUROLOGY, 2008, 60 (01) :1-11
[8]  
Freeman JA, 1996, J NEUROL REHABIL, V10, P185
[9]   Comparison of adherence and persistence among multiple sclerosis patients treated with disease-modifying therapies: a retrospective administrative claims analysis [J].
Halpern, Rachel ;
Agarwal, Sonalee ;
Dembek, Carole ;
Borton, Leigh ;
Lopez-Bresnahan, Maria .
PATIENT PREFERENCE AND ADHERENCE, 2011, 5 :73-84
[10]   Quality of life in patients with multiple sclerosis: The impact of fatigue and depression [J].
Janardhan, V ;
Bakshi, R .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2002, 205 (01) :51-58